NIR-II-absorbing Conjugated Polymer-Based Theranostic Agent for NIR-II Fluorescence Imaging-Guided Photothermal Therapy Acting Synergistically with Tumor Microenvironment-Responsive Nitric Oxide Therapy

Jie Li,Lisi Xie,Wei Sang,Wenxi Li,Guohao Wang,Hao Tian,Zhan Zhang,Jianhua Liu,Quli Fan,Yunlu Dai
DOI: https://doi.org/10.1016/j.chphma.2021.09.004
2021-01-01
ChemPhysMater
Abstract:Despite tremendous advances in gas therapy,there are major concerns about the inevitable concentration of toxicity and the ability to perform real-time tracking of drug delivery.Second near-infrared(NIR-Ⅱ)window absorbing nanoplatforms hold great promise for precision medicine because of their excellent tissue penetration of light and non-invasive nature.In this study,we engineered an NIR-Ⅱ laser-activated theranostic agent(named CP-bF@PEG)that was composed of amphiphilic polymers(Pluronic F127,with polyethylene glycol,PEG,moieties)coated with an NIR-Ⅱ-absorbing conjugated polymer(PTTBBT,CP)and nitric oxide(NO)donor(benzofuroxan,bF),which served as an NIR-Ⅱ photothermal inducer and NO nanogenerator.Under deep tissue penetration of NIR-Ⅱ laser irradiation,CP-bF@PEG was found to possess fluorescence imaging ability to accurately identify tumor and excellent photothermal effect.Moreover,CP-bF@PEG could generate NO via glutathione activation in the tumor microenvironment in a controllable manner.This NIR-Ⅱ-absorbing polymer for high-contrast NIR-Ⅱ fluorescence imaging-guided precision photothermal therapy achieved synergistic effects with NO therapy,as evidenced by pronounced tumor therapeutic efficacy and few side effects.This nanotheranostic agent is a highly promising candidate for high-contrast NIR-Ⅱ imaging-guided precision photothermal therapy combined with gas therapy against cancer.
What problem does this paper attempt to address?